Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5858456 | 0.79 | TET2 (0.30) | TET2 | |
| SCHEMBL6063759 | 0.75 | — | — | |
| SCHEMBL6063756 | 0.75 | — | — | |
| SCHEMBL203037 | 0.73 | — | — | |
| SCHEMBL966620 | 0.73 | — | — | |
| SCHEMBL5139476 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL25206010 | 0.71 | TET2 (0.34) | TET2 | |
| Bromide SCHEMBL27897349 | 0.71 | TET2 (0.34) | TET2 | |
| Fluoride SCHEMBL28844279 | 0.71 | TET2 (0.34) | TET2 | |
| Iodide SCHEMBL27914812 | 0.71 | TET2 (0.34) | TET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7148363-B2 | Process for preparing acrylate compound | TOSOH CORPORATION (JP) | 2006-12-12 | — | — | US | disclosed |
| US-20050148789-A1 | Process for preparing acrylate compound | TOSOH CORPORATION | 2005-07-07 | — | — | US | disclosed |
| US-6833462-B2 | Esterification to get cyclic acrylate compounds; used as raw material for functional polymers, pharmaceuticals, pesticides, semiconductor lithography | TOSOH CORPORATION (JP) | 2004-12-21 | — | — | US | disclosed |
| US-20030139613-A1 | Process for preparing acrylate compound | TOSOH CORPORATION | 2003-07-24 | — | — | US | disclosed |
| EP-0451266-B1 | Method of manufacturing a plastic graded-index optical transmission element | MITSUBISHI RAYON CO (JP) | 1995-12-13 | — | — | EP | disclosed |
| US-5390274-A | Distributed graded index type optical transmission plastic article and method of manufacturing same | MITSUBISHI RAYON COMPANY LTD. (JP) | 1995-02-14 | — | — | US | disclosed |
| EP-0451266-A1 | Method of manufacturing a plastic graded-index optical transmission element | MITSUBISHI RAYON CO., LTD. (JP) | 1991-10-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139613-A1 | Process for preparing acrylate compound | AFF1, AFF4, RER1 | TET2 1456/4885 |
| US-20050148789-A1 | Process for preparing acrylate compound | ACR, AFF4, AFF1 | TET2 1202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.